Brief: Aequus & Medicom Healthcare Sign Exclusive Term Sheet To Jointly Advance Ophthalmology Products Into USA
Dec 13 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* AEQUUS AND MEDICOM HEALTHCARE SIGN EXCLUSIVE TERM SHEET TO
JOINTLY ADVANCE OPHTHALMOLOGY PRODUCTS INTO THE USA
* AEQUUS - STRUCTURE OF DEAL IS AKIN TO JV, WITH REVENUES
SHARED
EQUALLY AND INVESTMENTS AND CONTRIBUTIONS MADE BY EACH PARTY
* AEQUUS - CO & MEDICOM WILL JOINTLY COMMERCIALIZE MEDICOM'S
RANGE
OF PRESERVATIVE FREE OPHTHALMICS IN U.S.
Source text for Eikon: ID:nGNX5GQ4N7
Further company coverage: AQS.V
((Reuters.briefs@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange